| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |